651 Molecular signature of neoantigen-reactive CD4+ and CD8+ T cells from metastatic human cancers enables prospective antitumor TCR prediction

• Steven Rosenberg,
• Maria Parkhurst,
• Paul Robbins,
• Nikolaos Zacharakis,
• Frank Lowery,
• Sri Krishna,
• Rami Yoseph,
• Neilesh Parikh,
• Praveen Chatani,
• Yong-Chen William Lu

Affiliations

Steven Rosenberg

NCI, Bethesda, MD, USA

Maria Parkhurst

Aff1 grid.48336.3a0000000419368075NIH/NCI/Surgery Branch Bethesda MD United States

Paul Robbins

Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA

Nikolaos Zacharakis

Aff102 grid.48336.3a0000000419368075Surgery BranchNational Cancer Institute, National Institutes of Health Bethesda MD USA

Frank Lowery

National Cancer Institute, Bethesda, MD, United States

Sri Krishna

National Cancer Institute, Bethesda, MD, United States

Rami Yoseph

NCI, Bethesda, MD, United States

Neilesh Parikh

NCI, Bethesda, MD, United States

Praveen Chatani

NCI, Bethesda, MD, United States

Yong-Chen William Lu

NCI, Bethesda, MD, United States